Home Newsfeeds Vera Therapeutics Q3 EPS $(0.91) Down From $(0.36) YoY

Vera Therapeutics Q3 EPS $(0.91) Down From $(0.36) YoY

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.91) per share. This is a 152.78 percent decrease over losses of $(0.36) per share from the same period last year.

byBenzinga Newsdesk

November 9, 2022

1 minute read

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.91) per share. This is a 152.78 percent decrease over losses of $(0.36) per share from the same period last year.

Legal
News

AMMO Acknowledges Receipt Of Urvan Lawsuit

By Happy Mohamed

May 4, 5:08 PM

AMMO, Inc. (NASDAQ:POWW, POWWP)))) ("AMMO" or the "Company"), the owner of GunBroker.com, the largest online marketplace serving the firearms and shooting sports industries, and a leading vertically

POWW

Xilio Therapeutics Q3 EPS $(0.72) Up From $(21.27) YoY

By Benzinga Newsdesk

November 9, 8:36 AM

Xilio Therapeutics (NASDAQ:XLO) reported quarterly losses of $(0.72) per share. This is a 96.61 percent increase over losses of $(21.27) per share from the same period last year.

XLO

A Look Into Xerox Holdings’ Debt

By Benzinga Insights

January 3, 2:09 PM

Shares of Xerox Holdings Inc. (NASDAQ:XRX) rose by 3.67% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.

XRX